Open AccessFoxO1 inhibition alleviates type 2 diabetes-related diastolic dysfunction by increasing myocardial pyruvate dehydrogenase activity
Author(s) -
Keshav Gopal,
Rami Al Batran,
Tariq Altamimi,
Amanda A. Greenwell,
Christina T. Saed,
Seyed Amirhossein Tabatabaei Dakhili,
M. Toni E. Dimaano,
Yongneng Zhang,
Farah Eaton,
Gopinath Sutendra,
John R. Ussher
Publication year - 2021
Publication title -
cell reports
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2021.108935
Subject(s) - diabetic cardiomyopathy , medicine , endocrinology , foxo1 , diastole , cardiomyopathy , heart failure , pyruvate dehydrogenase complex , enzyme , biology , phosphorylation , blood pressure , biochemistry , protein kinase b
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom